5^th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 16-18, 2015 Crowne Plaza, Dubai, UAE

Balaji V. Kadri, is currently Director of Formulation Development & Clinical Manufacturing at QS Pharma, LLC. Mr. Kadri has more than 18 years of formulation and process development experience within the contract research and generic industry. He was previously senior director of Pharmaceutical Operations at PharmaForm, where he was responsible for analytical, formulation development, and cGMP manufacturing. Prior to that, he headed the Preformulation and Formulation Development group at Xcelience, LLC for 10 years. He previously worked in formulation development and scale-up manufacturing at Apotex for six years. His broad dosage form experience includes immediate release tablets and capsules, sustained release capsules/tablets/beads, liquid/semi-solid in capsule, gels, paediatric solutions, suspensions, and parenteral. His expertise includes formulation development from preclinical to commercialization, overcoming solubilization challenges, enhancing bioavailability, taste masking, and development of controlled release dosage forms. He has authored numerous articles, presented many abstracts, is co-inventor of several patents and is a contributor of several excipient monographs in “Handbook of Pharmaceutical Excipients” 7th edition (2012). He is an active member of the American Association of Pharmaceutical Scientists (AAPS) and a registered life member in the Karnataka State Pharmacy Council in India.

Formulation development

Dr. Bootman has served as Dean of The University of Arizona College of Pharmacy since 1987. He is professor of pharmacy, medicine and public health, and a Fellow of several professional associations including the American Pharmacists Association, American Association of Pharmaceutical Scientists and the American College of Apothecaries. He is the Founding and Executive Director of the University of Arizona Center for Health Outcomes and PharmacoEconomic Research, one of the first such centers developed in the world. He received his pharmacy education at The University of Arizona and his doctorate at The University of Minnesota. In 2008 he was recognized with the Joseph P. Remington Honor Medal, the highest honor given by the profession of pharmacy to recognize distinguished service and lifetime contributions.

Pharmaceutics and Novel Drug Delivery

Professor Al-Ghananeem is the Associate Dean of Research and Graduate Program at Sullivan University College of Pharmacy, Kentucky, USA. She has completed her Ph.D. in Pharmaceutical Sciences from University of Kentucky, USA. Dr. Al-Ghananeem is an author of over 60 peer-reviewed research articles, symposium abstracts, and patent applications. She serves on the Editorial Advisory Board for many reputable pharmaceutical and clinical journals. Her research focuses on developing innovative formulation technologies for transmucosal, oral, and parenteral drug delivery. Her interests also include process development of various dosage forms and formulations for industrial technology transfer.

Developing innovative technologies for transmucosal, oral, and parenteral drug delivery and development of various dosage forms and formulations for industrial technology transfer.

Dr.Pillai received his B.Pharm (1965) and M.Pharm (1967) from Birla Institute of Technology and Science, India and MSc (1981) and PhD (1984) from the University of British Columbia, Vancouver, Canada. He was a professor of Pharmaceutics, at the Jordan University of Science and Technology, Jordan and at the University of the West Indies, Trinidad from 1998-2009 as professor and Director of the School of Pharmacy. While in Trinidad, He also served as a member of the Drug Advisory committee, Ministry of Health, Government of Trinidad & Tobago, an honorary appointment by the Minister of Health. He represented Trinidad at the PAHO/WHO sponsored conferences on "Pharmaceutical education in the Caribbean" in Barbados, Bahamas, Buenos Aires and Montevideo. He alsosupervised the research work of 14 post graduate students and four PhD students.

His area of research include development of analytical methods for drug analysis in biofluids for the study of Pharmacokinetics and drug metabolism and for stereoselective drug disposition; nanotechnology-based drug delivery systems for anticancer, anti-inflammatory agents and antibiotics and evaluation of bioequivalence of generic drug product.

Emmanuel Chinedum Ibezim is a professor of pharmaceutics at the University of Nigeria, Nsukka. He teaches undergraduate and graduate students and supervises Masters as well as Ph D students. Currently, he has successfully supervised about 22 postgraduate students and is supervising about 30 others. He has reviewed papers for about 39 scientific journals, edits two journals and serves in the editorial board of several others. He has attended not less than 88 scientific conferences nationally and internationally. He has undertaken collaborative researches with various scientists in institutions abroad where he visited, namely, notable drug research institutions in Asia (India) and South America (Brazil and Argentina).

His research interests include drug interactions, drug excipients development, new drug discoveries, molecular modeling, herbal medical formulations, novel drug delivery systems, drug utilization studies.

Dr. Ibrahim M. El-Bagory, PhD Is Professor of Pharmaceutics, College of Pharmacy, Al-Jouf University. He gained a PhD in Pharmaceutics and Pharmaceutical Technology from the University of British Columbia, Canada. Dr. El-Bagory has more than 30 internationally published research papers focused in nuclear pharmacy, evaluation of degree of crystallinity of drugs and excipients, preformulation studies for some solid dosage forms, bioavailability and pharmacokinetics of number of drugs.

Research interests are focused on the following aspects: •Physicochemical characterization of the materials including the dried particles, micro-spheres, mixtures and colloidal dispersions. •State the degree of hydration or salvation and their effects on pharmaceutical important properties such as stability, dissolution and bioavailability. •Preparation, formulation and characterization of micro-spheres.

Professor Bayomi received his Ph.D from the University of Connecticut, USA. He is now a professor of pharmaceutics at King Saud University, Saudi Arabia. He published many articles in reputed journals concerning microparticles, nanoparticles, liposomal formulations, drug targeting, and in-vivo evaluation of dosage forms. Dr. Bayomi was involved in different research projects funded by the college of pharmacy research center and King Abdul Aziz City of Science and Technology. He is serving as an advisory board member of local and international Journals.

He is interested in pharmaceutical technology and biotechnology.

Hanaa Elsaghir is currently a professor and vice chairman of department of pharmaceutics and pharmaceutical technology at King Saud University at King Saud University .Prof. Hanaa has completed her PhD from Cairo University through a joined PhD program with school of pharmacy Munster University, Germany. She had a post doctor fellowship at the university of Georgia, Athens, USA in 1989. She had published more than 45 scientific papers in national and international scientific journals. In addition she serves as a reviewer for several journals.

Her research interest in the area of nano and micro encapsulation of pharmaceutical preparation, solubilization of drugs, target drug delivery and controlled release.

Dr. Alsuwayeh is Professor and Chairman of the Department of Pharmaceutics, College of pharmacy, King Saud University, Riyadh, Saudi Arabia. He obtained a Masters degree from the University of Mississippi (USA) in 1991 and obtained Ph.D. degree from the University of Florida (USA) in 1997. Dr. Alsuwayeh has 14 year experience in drug and manufacturer regulation and registration in Saudi Arabia and GCC countries, 7 years of which as chairman of the safety and efficacy technical registration committee in the Saudi Ministry of Health and recently the Saudi FDA. He also has extensive experience in conducting and evaluating bioequivalence studies. In addition, he contributed to writing and updating many guidelines for the Saudi FDA.

Pharmaceutics and Novel Drug Delivery

Prof. Dr. Mahrous Osman Ahmed is a Vice Dean of Community Services and Environmental Affairs of Faculty of Pharmacy , Assiut University. Egypt since 2011. He is a professor of Industrial Pharmacy. He accomplished his Ph. D. from Assiut University in combined channel system with Chiba University, Japan (Interaction of certain benzodiazepines with Cyclodextrins). He has experience in tablet manufacturing technology, quality control, solubility techniques, drug delivery systems, in addition to experience of DSC, PXRD, FT-IR, HPLC and drug-drug and drug-excipients interactions. He has more than 50 published research papers and book chapters.

Drug delivery systems, solubility techniques

Abraham J. Domb is a Professor for Medicinal Chemistry and Biopolymers at the Faculty of Medicine of the Hebrew University of Jerusalem. He earned Bachelor degrees in Chemistry, Pharmaceutics and Law studies and PhD degree in Chemistry from The Hebrew University. He did his postdoctoral training at MIT and Harvard Univ. Cambridge USA and was R&D manager at Nova Pharm. Co. Baltimore US. Since 1991 he is a faculty member at the Hebrew university.

Nanoparticle Drug Delivery

Prof. Maha Aboul Ela, graduate of Faculty of Pharmacy, University of Alexandria, Egypt.Ph.D. in Pharmaceutical Sciences (Pharmacognosy) 1991, University of Alexandria-Egypt and Technical University of Berlin-Germany. Postdoctoral fellowship, School of Pharmacy, University of London, UK. Member of the American Society of Pharmacognosy. Member of the editorial board of many international scientific journals. Currently, head of department of Pharmaceutical Sciences, Faculty of Pharmacy, Beirut Arab University, Lebanon. Expert in QA in Higher Education.

Phytochemistry, Phytotherapy, discovering new drugs from natural sources and participation in drug development through applying different pharmaceutical approaches, more than 55 publications in the field of phytochemistry, medicinal plants and phytotherapy.

Fatemeh Ahmadi completed her Pharm D, School of Pharmacy, Shiraz University of Medical Sciences,Shiraz, Iran in 1996-2003. Completed her PhD, Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran in 2003-2010.

1- Targeted drug delivery systems based on prodrugs and polymeric constructs 2- Cationic structurally-modified polymers for gene delivery